Feasibility of integrated, multilevel care for cardiovascular diseases (CVD) and HIV in low- and middle-income countries (LMICs): A scoping review.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
06
11
2018
accepted:
30
01
2019
entrez:
23
2
2019
pubmed:
23
2
2019
medline:
19
11
2019
Statut:
epublish
Résumé
Integrated cardiovascular disease (CVD) and HIV (CVD-HIV) care interventions are being adopted to tackle the growing burden of noncommunicable diseases (NCDs) in low-and middle-income countries (LMICs) but there is a paucity of studies on the feasibility of these interventions in LMICs. This scoping review aims to present evidence of the feasibility of integrated CVD-HIV care in LMICs, and the alignment of feasibility reporting in LMICs with the existing implementation science methodology. A systematic search of published articles including systematic and narrative reviews that reported on integrated CVD-HIV care was conducted, using multiple search engines including PubMed/Medline, Global Health, and Web of Science. We examined the articles for evidence of feasibility reporting. Adopting the definition of Proctor and colleagues (2011), feasibility was defined as the extent to which an intervention was plausible in a given agency or setting. Evidence from the articles was synthesized by level of integration, the chronic care continuum, and stages of intervention development. Twenty studies, reported in 18 articles and 3 conferences abstracts, reported on feasibility of integrated CVD-HIV care interventions. These studies were conducted in Sub-Saharan Africa, Southeast Asia and South America. Four of these studies were conducted as feasibility studies. Eighty percent of the studies reported feasibility, using descriptive sentences that included words synonymous with feasibility terminologies in existing definition recommended by Proctor and colleagues. There was also an overlap in the use of descriptive phrases for feasibility amongst the selected studies. Integrating CVD and HIV care is feasible in LMICs, although methodology for reporting feasibility is inconsistent. Assessing feasibility based on settings and integration goals will provide a unique perspective of the implementation landscape in LMICs. There is a need for consistency in measures in order to accurately assess the feasibility of integrated CVD-HIV care in LMICs.
Sections du résumé
BACKGROUND
Integrated cardiovascular disease (CVD) and HIV (CVD-HIV) care interventions are being adopted to tackle the growing burden of noncommunicable diseases (NCDs) in low-and middle-income countries (LMICs) but there is a paucity of studies on the feasibility of these interventions in LMICs. This scoping review aims to present evidence of the feasibility of integrated CVD-HIV care in LMICs, and the alignment of feasibility reporting in LMICs with the existing implementation science methodology.
METHODS
A systematic search of published articles including systematic and narrative reviews that reported on integrated CVD-HIV care was conducted, using multiple search engines including PubMed/Medline, Global Health, and Web of Science. We examined the articles for evidence of feasibility reporting. Adopting the definition of Proctor and colleagues (2011), feasibility was defined as the extent to which an intervention was plausible in a given agency or setting. Evidence from the articles was synthesized by level of integration, the chronic care continuum, and stages of intervention development.
RESULTS
Twenty studies, reported in 18 articles and 3 conferences abstracts, reported on feasibility of integrated CVD-HIV care interventions. These studies were conducted in Sub-Saharan Africa, Southeast Asia and South America. Four of these studies were conducted as feasibility studies. Eighty percent of the studies reported feasibility, using descriptive sentences that included words synonymous with feasibility terminologies in existing definition recommended by Proctor and colleagues. There was also an overlap in the use of descriptive phrases for feasibility amongst the selected studies.
CONCLUSIONS
Integrating CVD and HIV care is feasible in LMICs, although methodology for reporting feasibility is inconsistent. Assessing feasibility based on settings and integration goals will provide a unique perspective of the implementation landscape in LMICs. There is a need for consistency in measures in order to accurately assess the feasibility of integrated CVD-HIV care in LMICs.
Identifiants
pubmed: 30794591
doi: 10.1371/journal.pone.0212296
pii: PONE-D-18-32018
pmc: PMC6386271
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0212296Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Int AIDS Soc. 2018 Mar;21(3):e25099
pubmed: 29577617
J Acquir Immune Defic Syndr. 2016 Nov 01;73(3):e39-e45
pubmed: 27741031
Epidemiol Perspect Innov. 2006 Apr 12;3:4
pubmed: 16608529
Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
BMC Public Health. 2013 Dec 09;13:1151
pubmed: 24321133
AIDS. 2018 Jul 1;32 Suppl 1:S93-S105
pubmed: 29952795
Health Policy Plan. 2012 Oct;27 Suppl 4:iv1-3
pubmed: 23014149
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):472-479
pubmed: 28640065
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
PLoS One. 2010 Jul 13;5(7):e11522
pubmed: 20644629
Open AIDS J. 2015 Oct 20;9:51-9
pubmed: 26587072
PLoS Med. 2016 Nov 22;13(11):e1002178
pubmed: 27875542
AIDS Care. 2018 Jan;30(1):103-115
pubmed: 28679283
Trop Med Int Health. 2013 Mar;18(3):328-43
pubmed: 23289364
Lancet. 2014 Jan 11;383(9912):156-65
pubmed: 24411644
Malawi Med J. 2017 Jun;29(2):78-83
pubmed: 28955411
PLoS One. 2015 Jul 13;10(7):e0131737
pubmed: 26167926
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Pilot Feasibility Stud. 2015 Oct 26;1:36
pubmed: 27965814
Trans R Soc Trop Med Hyg. 2015 Jul;109(7):440-6
pubmed: 25997923
Global Health. 2013 May 16;9:21
pubmed: 23680083
Trop Med Int Health. 2017 Aug;22(8):926-937
pubmed: 28544500
Trop Med Int Health. 2015 Oct;20(10):1265-70
pubmed: 25962952
J Int AIDS Soc. 2017 Mar 29;20(1):21514
pubmed: 28406269
PLoS One. 2013 Nov 13;8(11):e80017
pubmed: 24236170
Bull World Health Organ. 2007 Nov;85(11):880-5
pubmed: 18038079
Health Policy Plan. 2017 Mar 1;32(2):257-266
pubmed: 28207046
Afr J Prim Health Care Fam Med. 2017 Feb 15;9(1):e1-e8
pubmed: 28235324
Reprod Health Matters. 2001 Nov;9(18):69-78
pubmed: 11765403
Am J Hypertens. 1997 Jun;10(6):634-9
pubmed: 9194509
Healthc (Amst). 2015 Dec;3(4):270-6
pubmed: 26699356
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
BMC Public Health. 2016 Sep 21;16(1):1002
pubmed: 27655406